Edward Sturchio
General Counsel at IMMATICS N.V.
Net worth: 1 M $ as of 30/03/2024
Profile
Edward Sturchio is currently the General Counsel at Immatics NV since 2020.
Prior to this, he worked as the Secretary, Senior Vice President & General Counsel at Abeona Therapeutics, Inc. from 2019 to 2020, and as the Secretary & Global General Counsel at Advanced Accelerator Applications SA from 2016 to 2018.
He completed his undergraduate degree at Villanova University and his graduate degree at Seton Hall University School of Law.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
IMMATICS N.V.
0.10% | 30/01/2024 | 106,875 ( 0.10% ) | 1 M $ | 30/03/2024 |
Edward Sturchio active positions
| Companies | Position | Start |
|---|---|---|
| IMMATICS N.V. | General Counsel | 31/05/2020 |
Former positions of Edward Sturchio
| Companies | Position | End |
|---|---|---|
| ABEONA THERAPEUTICS INC. | General Counsel | 31/01/2020 |
| ADVANCED ACCELERATOR APPLICATION SA(ADR) | General Counsel | 31/07/2018 |
Training of Edward Sturchio
| Villanova University | Undergraduate Degree |
| Seton Hall University School of Law | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| ABEONA THERAPEUTICS INC. | Health Technology |
| IMMATICS N.V. | Health Technology |
| Private companies | 1 |
|---|---|
Advanced Accelerator Applications SA
 Advanced Accelerator Applications SA Medical SpecialtiesHealth Technology Advanced Accelerator Applications SA is a radiopharmaceutical company, which develops, produces and commercializes molecular nuclear medicine products. The firm offers research and development in medicinal and pharmaceutical therapeutic products mainly focusing in cardiology and neurology. It manufactures both diagnostic and therapeutic MNM products for commercialization. The company was founded by Stefano Buono in 2002 and is headquartered in Rueil-Malmaison Cedex, France. | Health Technology |
- Stock Market
- Insiders
- Edward Sturchio
